Quantum Biopharma Ltd. Files June 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Jun 17, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Jun 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, corporate-info, sec-filing
TL;DR
Quantum Biopharma (fka FSD Pharma) filed its June 6-K, confirming Toronto HQ and 20-F annual filings.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on June 17, 2025, reporting for the month of June 2025. The company, incorporated in A6 with its principal executive office in Toronto, Canada, is a pharmaceutical preparations company. This filing indicates they are submitting their report under the 1934 Act and will file annual reports under Form 20-F.
Why It Matters
This filing provides an update on Quantum Biopharma's reporting status and corporate information, which is crucial for investors tracking the company's compliance and regulatory activities.
Risk Assessment
Risk Level: low — This is a routine periodic filing (6-K) that primarily provides corporate information and does not appear to contain significant new operational or financial developments.
Key Numbers
- 001-39152 — SEC File Number (Identifies the company's filing with the SEC.)
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Registrant
- FSD Pharma Inc. (company) — Former company name
- 20250617 (date) — Filing date and period of report
- Toronto, Canada (location) — Principal executive office location
- 001-39152 (other) — SEC file number
- 2834 (other) — Standard Industrial Classification (Pharmaceutical Preparations)
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of June 2025.
What was Quantum Biopharma Ltd.'s former name?
Quantum Biopharma Ltd.'s former name was FSD Pharma Inc., with a date of name change on March 27, 2019.
Where is Quantum Biopharma Ltd.'s principal executive office located?
The company's principal executive office is located at 55 University Ave., Suite 1003, Toronto, Ontario, M5J2H7, Canada.
Under which form will Quantum Biopharma Ltd. file its annual reports?
Quantum Biopharma Ltd. indicates it will file annual reports under cover of Form 20-F.
What is Quantum Biopharma Ltd.'s Standard Industrial Classification code?
The company's Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 17, 2025 regarding Quantum Biopharma Ltd. (QNTM).